Virtual Reality Therapy for Lazy Eye More Effective Than Traditional Patching with Scott Xiao Luminopia TRANSCRIPT
Release Date: 05/04/2026
Empowered Patient Podcast
Patty Hayward, General Manager of healthcare and life sciences at Talkdesk, describes how a hybrid model of humans and AI is reshaping healthcare contact centers. Patient access and revenue cycle management are the primary, interconnected challenges for these centers, and modern large-language AI is being used to handle complex scheduling logic. Data analytics helps identify patterns in patient inquiries, predict demand peaks, and move care from reactive to proactive. The expectation is that AI agents will guide patients, becoming a normal and accepted part of healthcare. Patty explains, "I...
info_outlineEmpowered Patient Podcast
Patty Hayward, General Manager of healthcare and life sciences at Talkdesk, describes how a hybrid model of humans and AI is reshaping healthcare contact centers. Patient access and revenue cycle management are the primary, interconnected challenges for these centers, and modern large-language AI is being used to handle complex scheduling logic. Data analytics helps identify patterns in patient inquiries, predict demand peaks, and move care from reactive to proactive. The expectation is that AI agents will guide patients, becoming a normal and accepted part of healthcare. Patty explains, "I...
info_outlineEmpowered Patient Podcast
Scott Xiao, Co-Founder and CEO of Luminopia, is developing a novel, FDA -cleared VR-based treatment for neurovisual disorders with a primary focus on amblyopia, lazy eye, in children aged 4- 12 years old. This approach uses popular TV shows to create an engaging, effective therapy that trains the eyes to work together and is designed as a replacement for traditional eye patching. Clinical data indicate that the vision improvements from this therapy are durable and that the VR approach is well-received by children and their parents. Scott explains, "We are pioneering a new class of...
info_outlineEmpowered Patient Podcast
Scott Xiao, Co-Founder and CEO of Luminopia, is developing a novel, FDA -cleared VR-based treatment for neurovisual disorders with a primary focus on amblyopia, lazy eye, in children aged 4- 12 years old. This approach uses popular TV shows to create an engaging, effective therapy that trains the eyes to work together and is designed as a replacement for traditional eye patching. Clinical data indicate that the vision improvements from this therapy are durable and that the VR approach is well-received by children and their parents. Scott explains, "We are pioneering a new class of...
info_outlineEmpowered Patient Podcast
Joseph Kleiman, President of Buzz Health, is working to improve price transparency and affordability of prescription drugs. He states that providing price transparency as early as possible in the prescription process is critical for prescribers, patients, and health plans to make better, more cost-effective decisions. To achieve true transparency, all parties in the ecosystem must cooperate and share data, moving beyond pricing visibility to fully integrate systems and use real-time information to improve patient adherence and lower costs. Joseph explains, "Buzz Health really focuses on...
info_outlineEmpowered Patient Podcast
Joseph Kleiman, President of Buzz Health, is working to improve price transparency and affordability of prescription drugs. He states that providing price transparency as early as possible in the prescription process is critical for prescribers, patients, and health plans to make better, more cost-effective decisions. To achieve true transparency, all parties in the ecosystem must cooperate and share data, moving beyond pricing visibility to fully integrate systems and use real-time information to improve patient adherence and lower costs. Joseph explains, "Buzz Health really focuses on...
info_outlineEmpowered Patient Podcast
Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, highlights the critical role of advanced precision diagnostics and how these tools are driving true precision medicine, where therapies are targeted to specific genetic mutations. There have been significant innovations, such as less invasive liquid biopsies and the application of AI to interpret medical images and complex lab results, which provide faster analysis and make it easier to monitor disease over time. The future of diagnostics includes more routine tests and imaging to enable earlier interventions and more...
info_outlineEmpowered Patient Podcast
Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, highlights the critical role of advanced precision diagnostics and how these tools are driving true precision medicine, where therapies are targeted to specific genetic mutations. There have been significant innovations, such as less invasive liquid biopsies and the application of AI to interpret medical images and complex lab results, which provide faster analysis and make it easier to monitor disease over time. The future of diagnostics includes more routine tests and imaging to enable earlier interventions and more...
info_outlineEmpowered Patient Podcast
Zack Tisch, Partner of Portfolio Services, and Molly Kalinowski, Vice President of Managed Services at Pivot Point Consulting, describe how the role of IT in healthcare has evolved from a reactive, support function to a central strategic component of business. As AI becomes more important, healthcare systems are navigating a challenging environment and recognizing the need for managed services partners to handle day-to-day operations so they can better focus on big-picture goals and priorities. Zack and Molly emphasize the need to drive incremental changes to streamline provider data capture...
info_outlineEmpowered Patient Podcast
Zack Tisch, Partner of Portfolio Services, and Molly Kalinowski, Vice President of Managed Services at Pivot Point Consulting, describe how the role of IT in healthcare has evolved from a reactive, support function to a central strategic component of business. As AI becomes more important, healthcare systems are navigating a challenging environment and recognizing the need for managed services partners to handle day-to-day operations so they can better focus on big-picture goals and priorities. Zack and Molly emphasize the need to drive incremental changes to streamline provider data capture...
info_outlineScott Xiao, Co-Founder and CEO of Luminopia, is developing a novel, FDA -cleared VR-based treatment for neurovisual disorders with a primary focus on amblyopia, lazy eye, in children aged 4- 12 years old. This approach uses popular TV shows to create an engaging, effective therapy that trains the eyes to work together and is designed as a replacement for traditional eye patching. Clinical data indicate that the vision improvements from this therapy are durable and that the VR approach is well-received by children and their parents.
Scott explains, "We are pioneering a new class of treatments using virtual reality to treat various neurovisual disorders. So these are conditions where patients have vision loss that's driven by deficiencies in the brain, in the visual cortex. We're starting with amblyopia, which is often known as lazy eye. It's the number one cause of vision loss in children around the world. And it's an area of significant unmet need. There hasn't been much in the way of new treatments for decades. Typically, patients will go through glasses followed by eye patches, which is exactly what it sounds like. You take a patch, and you stick it on your stronger eye for multiple hours a day. And that's a really challenging treatment for a lot of kids and families. So we saw an opportunity to use technology to create something better, something that would be more engaging and more effective."
"We've developed a VR-based approach that takes popular TV shows like SpongeBob and Sesame Street and turns them into a treatment by modifying how the images are shown to each eye. And this technology has been extensively validated at this point in multiple clinical trials. It was cleared by the FDA, and it's now commercially available. So over the past year, we've really been making strides on the commercial front, increasing awareness for the product among physicians and patients, and securing insurance coverage for the product."
#Luminopia #Amblyopia #PediatricOphthalmology #VirtualReality #DigitalTherapeutics #LazyEye #VisionTherapy #Optometry #PediatricCare #HealthcareInnovation #MedicalTechnology
